Director, HEOR/RWE - Lung

Revolution Medicines•Redwood City, CA

20h•Onsite

About The Position

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director, HEOR/RWE is an integral part of the organization, responsible for executing HEOR plans and activities related to Revolution Medicines assets intended for use in lung cancer. This individual will be accountable for generating evidence that demonstrates the value of Revolution Medicines products to healthcare organizations, allowing them to make informed decisions. They will work closely with the Medical Affairs team as well as other cross-functional teams to optimize the Integrated Evidence Plan (IEP) and to deliver evidence supporting the use of Revolution Medicines products. This individual will serve as an HEOR expert internally and also while representing RevMed externally at industry conferences. This is an exceptional opportunity to contribute to the advancement of healthcare by providing evidence that can shape the future of patient care in oncology. Reporting to the Executive Director of HEOR/RWE Lung, the Director, HEOR/RWE Lung will:

Requirements

Deep expertise in health economics, outcomes research, patient-reported outcomes or related fields in the biotechnology or pharmaceutical industry.
Experience in oncology HEOR and RWE development.
Minimum 5 years of relevant experience with an advanced degree in a relevant field (MD, PhD, PharmD).
Track record of high impact publications in HEOR/RWE topics.
Strong written and interpersonal communication skills, with an ability to present complex technical information clearly.
Demonstrated ability to lead evidence generation initiatives and to communicate with impact internally and externally.
Knowledge and experience in managed care, integrated delivery networks, formulary decision-making, and payment/access models.
Ability to establish relationships with experts in real world evidence (RWE) and therapeutic areas of interest.

Nice To Haves

8+ years of relevant experience in the pharmaceutical/biotech industry.
Experience related to lung cancer.

Responsibilities

Execute the product HEOR/RWE strategy to deliver evidence consistent with the medical strategy and IEP.
Deliver HEOR/RWE tactics with quality and in alignment with agreed upon timing
Provide HEOR/RWE representation on matrix teams and working groups.
Work with the HEOR/RWE and Medical Affairs leadership to ensure critical value insights are communicated to key internal teams.
Provide HEOR evidence which addresses the needs and expectations of key stakeholders such as patients, healthcare providers, payers and Health Technology Assessment (HTA) agencies.
Effectively present research findings to internal and external stakeholders to improve internal decision making and to promote wider adoption of research findings across external stakeholders.
Facilitate the communication of the value proposition of Revolution Medicines’ portfolio, allowing key healthcare and formulary professionals to make informed therapeutic decisions.
Engage and collaborate with external partners including payers, health care providers, thought leaders, patient advocates, and decision-makers to establish/maintain strong partnerships and gather insights into research programs.
Stay up to date with and add to the advancements in health economics methodologies and best practices; support the build of disease area HEOR/RWE disease area capability, establishing best practices, external visibility, and functional excellence across the medical affairs network.
Identify and interface with HEOR & RWE experts and organizations, profile data sources and related organizations as they relate to Revolution Medicines’ portfolio and therapeutic areas.
Closely monitor new trends in health policy and payer environment, assess competitive data gaps and communicate to the organization, to help Revolution Medicines build industry-leading capabilities and be on the cutting edge of evidence-based medicine and HEOR research.